Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Periods.

Allison Avrich Ciesla,Ryan E Wiegand,Zachary R Smith,Amadea Britton,Katherine E Fleming-Dutra,Joseph Miller,Emma K Accorsi,Jennifer R Verani,Nong Shang,Gordana Derado,Tamara Pilishvili,Ruth Link-Gelles

Open forum infectious diseases（2023）

引用 1|浏览1

暂无评分

摘要

Monovalent mRNA booster doses provided additional protection against symptomatic SARS-CoV-2 infection during BA.2/BA.2.12.1 and BA.4/BA.5 subvariant circulation, but protection waned over time.

查看译文

关键词

booster doses,infection

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要